Navigation Links
Research and Markets Announces the Release of Global Biobank (Biospecimen/Biorepository/Biopreservation) Market For Equipment & Media – Trends & Forecast to 2017
Date:3/25/2013

(PRWEB) March 25, 2013

Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. Cryopreservation, vitrification and hypothermic storage are the common biopreservation procedures used widely in laboratory and clinical settings. The increase in cell-banking systems like adult stem cell banking, tissue banking, and umbilical cord blood banking has led to an increase in demand for the concept of biopreservation. Antibodies and proteins obtained from high-yielding cell-lines are required by biotech and pharmaceutical companies for research, diagnostic or clinical purposes. These high-yielding cell lines need to be preserved to give optimum yield, viability and productivity.

The global biobank (biospecimen/ biorepository/biopreservation) market for equipment and media is broadly categorized into two segments, namely, biopreservation media market, and biopreservation equipment market. These markets are dominated by the U.S. in 2012, followed by Europe, Asia, and Rest of the World (RoW), due to government investments and tremendous research activities in this geographical region.

The biobank (biospecimen/ biorepository/biopreservation) market for equipment and media is anticipated to show a sharp rise in Asia and RoW. This rise is due to increasing investments by government and non-government organizations. Biotechnology and pharmaceutical companies are also making investments for cell-based therapy research across the globe. There is increased awareness and adoption of cord blood banking among the people. Biobanks are getting established rapidly and research for treatment of cell and tissue disorders is on the rise. The main application areas driving the biobank (biospecimen/ biorepository/biopreservation) market for equipment and media are advances in regenerative medicine, biobanking and drug discovery. Despite restraints such as financial, ethical, regulatory and reimbursement issues, the biopreservation market is expected to grow in the next five years.

The global biobank (biospecimen/ biorepository/biopreservation) market for equipment and media witnesses high competitive intensity. Segment rivalry is high, as there are a few big firms and many small firms with similar product offerings. The firms operating in the market fight to garner market share, leading to frequent price wars, advertising battles, incessant launch of new products, and increased customer services & warranties.

The global biopreservation media market is dominated by home-brew media solutions, which account for nearly 71% of the market. Apart from home-brew media solutions, the major players operating in the biopreservation media market include Organ Recovery Systems, Teva Pharmaceuticals, and Genzyme. The global biopreservation equipment market has many well-established as well as local players dominating the industry market. Some of the major players are Thermofisher Scientific, Taylor-Wharton, and VWR International.

Scope of the Report

The research report categorizes the global biobank (biospecimen/ biorepository/biopreservation) market for equipment and media into two segments: biopreservation media market and biopreservation equipment market. Both of these markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for the years (2010, 2011 and 2012) as well as forecast up to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia and Rest of the World (RoW)) to provide in-depth information on the global scenario.

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager,
press(at)researchandmarkets(dot)com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Biotechnology

Read the full story at http://www.prweb.com/releases/2013/3/prweb10560727.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
2. UW researchers discover the brain origins of variation in pathological anxiety
3. Researchers decode biology of blood and iron disorders mapping out novel future therapies
4. Study: Research reveals protective properties of influenza vaccines
5. Researchers developing antiviral drug to combat contagious norovirus
6. Research: Women over 40 still need effective contraception
7. Cleveland Clinic's Mellen Center for Multiple Sclerosis Treatment and Research Honored for Workplace Practice that Promotes Health and Safety
8. Contract Research Organization, WCCT Global Announces Strong Focus for Early Phase Research for Obesity
9. WSU researchers to study effect of fatigue on attention
10. UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
11. Michigan Lupus Foundation Texas Hold 'Em Tournament Raises Thousands for Lupus Support, Education & Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that two of its ... of bioassays at two upcoming conferences. , At the BEBPA 10th Annual Bioassay ...
(Date:9/25/2017)... ... ... NCPDP Foundation , a 501(c)(3) nonprofit charitable organization ... grant to Johns Hopkins Medicine to address patient safety risk by implementing CancelRx ... a prescription already submitted to a pharmacy. Studies indicate that up to 3% ...
(Date:9/25/2017)... ... September 25, 2017 , ... Lean ... efficiency. The principle of First-Defect-Stop for laboratory weighing is designed to ... the chance to have negative consequences on downstream processes. , If a problem ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... technology-enabled services supporting clinical research, today announces that 30 of its domain ... the drug development lifecycle at upcoming industry conferences and webinars. Drawing on ...
(Date:9/25/2017)... ... September 25, 2017 , ... Ron Norman, CEO of Team ... upper-level executives speaking at a business luncheon today, "It is tantamount to forgetting ... asset to be fully realized and activated by the corporations that recognize their ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Healthcare Conference at the Grand Hyatt hotel in New ... 2017 at 11:40 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
Breaking Medicine Technology: